North America Glucose Monitoring Devices Market Forecast to 2030 - Regional Analysis - By Type, Application, Testing Type, and End User

Description

List of Tables

The North America glucose monitoring devices market is expected to grow from US$ 5,987.78 million in 2022 to US$ 14,409.58 million by 2030. It is estimated to grow at a CAGR of 11.6% from 2022 to 2030.

Rapid Technological Advancements in Glucose Monitoring Devices Fuel North America Glucose Monitoring Devices Market

Products with advanced technologies offer more effective benefits in diabetes treatment. As the prevalence of diabetes increases worldwide, the demand for more products with advancements also accelerates. Thus, researchers have been carrying out research activities resulting in product innovations over the years. There are many methods to deliver insulin into the body, such as needles, insulin pens, and insulin pumps. Insulin pumps are small, computerized diabetes management devices connected with a cannula under the skin to deliver a slow, continuous insulin level. The individual can control the program depending on the requirements. Optimal diabetes management depends on accurate glucose monitoring devices. The increasing advancements in glucose monitoring devices have resulted in smaller required blood volumes with improved accuracy. The ability to transfer data between the blood glucose meter and glucose monitoring devices has also been improved. The increasing advancements in blood glucose monitoring technology have improved accuracy, smaller required blood volumes, and the ability to transfer data between the blood glucose meter and glucose monitoring devices. In June 2022, Abbott announced a new bio wearable that continuously monitors glucose and ketone levels in one sensor. Thus, the technological advancements coupled with the increasing influx of new products are expected to propel the market growth over the forecast years.

North America Glucose Monitoring Devices Market Overview

The North America North America glucose monitoring devices market has been segmented into the US, Canada, and Mexico. The market growth in this region is attributed to the rising diabetic prevalence, and increasing geriatric population are main factors positively influencing the growth of the market. Additionally, technological advancements in monitoring devices further enhances the overall market growth during 2022-2030.

North America Glucose Monitoring Devices Market Revenue and Forecast to 2030 (US$ Million)

North America Glucose Monitoring Devices Market Segmentation

The North America glucose monitoring devices market is segmented into type, application, testing site, end- user, and country.

Based on type, the North America glucose monitoring devices market is segmented into continuous glucose monitoring devices and self-glucose monitoring devices. The self-glucose monitoring devices segment held a larger share of the North America glucose monitoring devices market in 2022.

Based on application, the North America glucose monitoring devices market is segmented into type 1 diabetes and type 2 diabetes. The type 2 diabetes segment held a larger share of the North America glucose monitoring devices market in 2022.

Based on testing site, the North America glucose monitoring devices market is segmented into fingertip testing and alternate site testing. The fingertip testing segment held a larger share of the North America glucose monitoring devices market in 2022.

Based on end user, the North America glucose monitoring devices market is segmented into healthcare setting and self/homecare. The self/homecare segment held a larger share of the North America glucose monitoring devices market in 2022.

Based on country, the North America glucose monitoring devices market is segmented int o the US, Canada, and Mexico. The US dominated the North America glucose monitoring devices market in 2022.

B. Braun SE, F. Hoffmann-La Roche Ltd, LifeScan Inc, Medtronic Plc, Abbott Laboratories, Ypsomed Holding AG, Senseonics Holdings Inc, Nipro Corp, and GE HealthCare Technologies Inc, and Terumo Corp are some of the leading companies operating in the North America glucose monitoring devices market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America glucose monitoring devices market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in North America glucose monitoring devices market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Product Code: BMIRE00029122

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Glucose Monitoring Devices Market - Key Industry Dynamics

4.1 Key Market Drivers
- 4.1.1 Rising Incidence of Diabetes
- 4.1.2 Growing Geriatric Population
- 4.1.3 Increasing Prevalence of Obesity
4.2 Key Market Restraints
- 4.2.1 High Cost of Glucose Monitoring Devices
4.3 Key Market Opportunities
- 4.3.1 Growing Medical Tourism in Developing Countries
4.4 Future Trends
- 4.4.1 Rapid Technological Advancements in Glucose Monitoring Devices

5. Glucose Monitoring Devices Market - North America Market Analysis

5.1 North America Glucose Monitoring Devices Market Revenue (US$ Mn), 2022 - 2030

6. North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 - by Type

6.1 Overview
6.2 North America Glucose Monitoring Devices Market Revenue Share, by Type 2022 & 2030 (%)
6.3 Continuous Glucose Monitoring Devices
- 6.3.1 Overview
- 6.3.2 Continuous Glucose Monitoring Devices: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.3.2.1 Sensors
    - 6.3.2.1.1 Sensors: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.3.2.2 Transmitters
    - 6.3.2.2.1 Transmitters: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.3.2.3 Receivers
    - 6.3.2.3.1 Receivers: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Self-Glucose Monitoring Devices
- 6.4.1 Overview
- 6.4.2 Self-Glucose Monitoring Devices: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.4.2.1 Testing Strips
    - 6.4.2.1.1 Testing Strips: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.4.2.2 Glucose Meters
    - 6.4.2.2.1 Glucose Meters: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.4.2.3 Lancets
    - 6.4.2.3.1 Lancets: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.4.2.4 Others
    - 6.4.2.4.1 Others: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 - by Application

7.1 Overview
7.2 North America Glucose Monitoring Devices Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Type 1 Diabetes
- 7.3.1 Overview
- 7.3.2 Type 1 Diabetes: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Type 2 Diabetes
- 7.4.1 Overview
- 7.4.2 Type 2 Diabetes: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 - by Testing Site

8.1 Overview
8.2 North America Glucose Monitoring Devices Market Revenue Share, by Testing Site 2022 & 2030 (%)
8.3 Fingertip Testing
- 8.3.1 Overview
- 8.3.2 Fingertip Testing: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Alternate Site Testing
- 8.4.1 Overview
- 8.4.2 Alternate Site Testing: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 North America Glucose Monitoring Devices Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Healthcare Settings
- 9.3.1 Overview
- 9.3.2 Healthcare Settings: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Self/Homecare
- 9.4.1 Overview
- 9.4.2 Self/Homecare: North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Glucose Monitoring Devices Market - Revenue and Forecast to 2030 -Country Analysis

10.1 North America: Glucose Monitoring Devices Market
- 10.1.1 Overview
- 10.1.2 North America: Glucose Monitoring Devices Market , by Country
  - 10.1.2.1 US: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.1.1 Overview
    - 10.1.2.1.2 US: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.1.3 US: North America Glucose Monitoring Devices Market , by Type, 2020-2030 (US$ Million)
    - 10.1.2.1.3.1 US: North America Glucose Monitoring Devices Market , by Continuous Glucose Monitoring Devices, 2020-2030 (US$ Million)
    - 10.1.2.1.3.2 US: North America Glucose Monitoring Devices Market , by Self-Glucose Monitoring Devices, 2020-2030 (US$ Million)
    - 10.1.2.1.4 US: North America Glucose Monitoring Devices Market , by Application, 2020-2030 (US$ Million)
    - 10.1.2.1.5 US: North America Glucose Monitoring Devices Market , by Testing Site, 2020-2030 (US$ Million)
    - 10.1.2.1.6 US: North America Glucose Monitoring Devices Market , by End User, 2020-2030 (US$ Million)
  - 10.1.2.2 Canada: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.2.1 Overview
    - 10.1.2.2.2 Canada: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.2.3 Canada Glucose Monitoring Devices Market , by Type, 2020-2030 (US$ Million)
    - 10.1.2.2.3.1 Canada Glucose Monitoring Devices Market , For Continuous Glucose Monitoring Devices, 2020-2030 (US$ Million)
    - 10.1.2.2.3.2 Canada Glucose Monitoring Devices Market , For Self-Glucose Monitoring Devices, 2020-2030 (US$ Million)
    - 10.1.2.2.4 Canada Glucose Monitoring Devices Market , by Application, 2020-2030 (US$ Million)
    - 10.1.2.2.5 Canada Glucose Monitoring Devices Market , by Testing Site, 2020-2030 (US$ Million)
    - 10.1.2.2.6 Canada Glucose Monitoring Devices Market , by End User, 2020-2030 (US$ Million)
  - 10.1.2.3 Mexico Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.3.1 Overview
    - 10.1.2.3.2 Canada: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.3.3 Mexico Glucose Monitoring Devices Market , by Type, 2020-2030 (US$ Million)
    - 10.1.2.3.3.1 Mexico Glucose Monitoring Devices Market , For Continuous Glucose Monitoring Devices by Type, 2020-2030 (US$ Million)
    - 10.1.2.3.3.2 Mexico Glucose Monitoring Devices Market , For Self-Glucose Monitoring Devices by Type, 2020-2030 (US$ Million)
    - 10.1.2.3.4 Mexico Glucose Monitoring Devices Market , by Application, 2020-2030 (US$ Million)
    - 10.1.2.3.5 Mexico Glucose Monitoring Devices Market , by Testing Site, 2020-2030 (US$ Million)
    - 10.1.2.3.6 Mexico Glucose Monitoring Devices Market , by End User, 2020-2030 (US$ Million)

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in the North America North America Glucose Monitoring Devices Market
11.3 Organic Developments
- 11.3.1 Overview
11.1 Inorganic Developments
- 11.1.1 Overview

12. Company Profiles

12.1 B. Braun SE
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 LifeScan Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Medtronic Plc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Abbott Laboratories
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Ypsomed Holding AG
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Senseonics Holdings Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Nipro Corp
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 GE HealthCare Technologies Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Terumo Corp
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms